مورد إلكتروني
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
| العنوان: | Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit |
|---|---|
| المؤلفون: | Semb, A.G., Rollefstad, S., Ikdahl, E., Wibetoe, G., Sexton, J., Crowson, C., Riel, P.L. van, Kitas, G., Graham, I., Rantapää-Dahlqvist, S., Karpouzas, G.A., Myasoedova, E., Gonzalez-Gay, M.A., Sfikakis, P.P., Tektonidou, M.G.G., Lazarini, A., Vassilopoulos, D., Kuriya, B., Hitchon, C., Stoenoiu, M.S., Durez, P., Pascual-Ramos, V., Galarza-Delgado, D.A., Faggiano, P., Misra, D.P., Borg, A.A., Mu, R., Mirrakhimov, E.M., Gheta, D., Douglas, K., Agarwal, V., Myasoedova, S., Krougly, L., Popkova, T. Valentinovna, Tuchyňová, A., Tomcik, M., Vrablik, M., Lastuvka, J., Horak, P., Medkova, H.K., Kerola, A.M. |
| المصدر: | Rheumatic & Musculoskeletal Diseases Open; 2056-5933; 2; vol. 7; e001724; ~Rheumatic & Musculoskeletal Diseases Open~~~~~2056-5933~2~7~~e001724 |
| بيانات النشر: | 2021 |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | Contains fulltext : 238631.pdf (Publisher’s version ) (Open Access) AIM: The objective was to examine the prevalence of atherosclerotic cardiovascular disease (ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and patients with RA without diabetes mellitus (RAwoDM), and to evaluate lipid and blood pressure (BP) goal attainment in RA-DM and RAwoDM in primary and secondary prevention. METHODS: The cohort was derived from the Survey of Cardiovascular Disease Risk Factors in Patients with Rheumatoid Arthritis from 53 centres/19 countries/3 continents during 2014-2019. We evaluated the prevalence of cardiovascular disease (CVD) among RA-DM and RAwoDM. The study population was divided into those with and without ASCVD, and within these groups we compared risk factors and CVD preventive treatment between RA-DM and RAwoDM. RESULTS: The study population comprised of 10 543 patients with RA, of whom 1381 (13%) had DM. ASCVD was present in 26.7% in RA-DM compared with 11.6% RAwoDM (p<0.001). The proportion of patients with a diagnosis of hypertension, hyperlipidaemia and use of lipid-lowering or antihypertensive agents was higher among RA-DM than RAwoDM (p<0.001 for all). The majority of patients with ASCVD did not reach the lipid goal of low-density lipoprotein cholesterol <1.8 mmol/L. The lipid goal attainment was statistically and clinically significantly higher in RA-DM compared with RAwoDM both for patients with and without ASCVD. The systolic BP target of <140 mm Hg was reached by the majority of patients, and there were no statistically nor clinically significant differences in attainment of BP targets between RA-DM and RAwoDM. CONCLUSION: CVD preventive medication use and prevalence of ASCVD were higher in RA-DM than in RAwoDM, and lipid goals were also more frequently obtained in RA-DM. Lessons may be learnt from CVD prevention programmes in DM to clinically benefit patients with RA . |
| الإتاحة: | Open access content. Open access content |
| أرقام أخرى: | NLQGE oai:repository.ubn.ru.nl:2066/238631 https://repository.ubn.ru.nl//bitstream/handle/2066/238631/238631.pdf https://repository.ubn.ru.nl/handle/2066/238631 https://doi.org/10.1136/rmdopen-2021-001724 1280202195 |
| المصدر المساهم: | RADBOUD UNIVERSITEIT NAJMEGEN From OAIster®, provided by the OCLC Cooperative. |
| رقم الأكسشن: | edsoai.on1280202195 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |